Treatment group | Risk variables | Unadjusted OR (95% CI) | p-value | Adjusted OR (95% CI)* | p-value |
---|---|---|---|---|---|
SP (n = 50) | Parasite density | 3.74 (1.12–12.54) | 0.03 | 3.16 (0.73–13.71) | 0.13 |
 | CIRN | 4.67 (1.25–17.44) | 0.02 | 7.21 (1.42–36.73) | 0.02 |
 | GLURP-R0 | 0.09 (0.02–0.41) | 0.002 | 0.08 (0.14–0.47) | 0.005 |
AQ (n = 50) | Parasite density | 0.82 (0.27–2.46) | 0.72 | 0.77 (0.13–4.42) | 0.76 |
 | CVIET | 3.55 (0.85–14.91) | 0.08 | 2.56 (0.46–14.27) | 0.28 |
 | GLURP-R0 | 0.10 (0.02–0.43) | 0.002 | 0.07 (0.01–0.48) | 0.003 |
SP+AQ (n = 100) | Parasite density | 1.61 (0.74–3.47) | 0.23 | 1.13 (0.43–2.99) | 0.80 |
 | CIRN/CVIET | 3.76 (1.49–9.47) | 0.005 | 3.44 (1.12–10.54) | 0.03 |
 | GLURP-R0 | 0.13 (0.06–0.33) | < 0.001 | 0.11 (0.04–0.31) | < 0.001 |